Present data demonstrated that supplement of miR-375 in HPV-positive cancer cells coordinates the regulation of HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ, which secures the expression of tumor suppressors p53, RB, and p21, and regulates telomerase activity. The gene discussed is TP53; the disease is cancer.